Allergan Aesthetics Debuts AA Signature™ in the United States with SKIN360, Its First Multimodal Consultation Approach

AA Signature: SKIN360 marks the first in a series of assessment protocols addressing patients' evolving aesthetic goals. The program includes provider education and resources to support 96% of patients who are interested in a comprehensive aesthetic consultation. 1,2,† IRVINE, Calif. , Sept. 22, 2026 / PRNewswire / -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), the global industry leader in aesthetics, today announced the U.S. launch of AA Signature™ . Building on the program's successful international rollout and strong support from health care providers (HCPs), AA Signature is a collection of patient-centric, multimodal consultation approaches that leverage Allergan Medical Institute (AMI) resources and Allergan Aesthetics products. The program will launch with AA Signature ™ : SKIN360 , its first patient-centric consultation approach featuring SKINVIVE by JUVÉDERM ® , SkinMedica ®  HA 5®  Hydra Collagen Hydrator with Vegan Collagen, and BOTOX ®  Cosmetic (onabotulinumtoxinA). "At Allergan Aesthetics, we believe leadership means not only advancing science and innovation but also equipping providers with the tools they need to succeed in a rapidly evolving market," said Nicole Mowad-Nassar, senior vice president, AbbVie and president, Global Allergan Aesthetics. "AA Signature represents a new approach to treatment planning, helping HCPs deliver personalized, multimodal assessments backed by Allergan Aesthetics' robust product portfolio. By enabling more meaningful patient consultations and individualized treatment journeys, we are helping shape the future of aesthetic medicine." AA Signature is grounded in the art of consultation and provides HCPs with guidance on how to conduct structured, comprehensive facial assessments. Research shows that 96% of patients are interested in a comprehensive assessment and at the same time, practices that take a comprehensive, multimodal approach to treatment planning see 68% higher patient retention than those treating a single concern. 1-4,*  Thorough consultations are critical to informing treatment plans that level set expectations to help patients achieve their individual aesthetic goals. Allergan Aesthetics conducted a brand-agnostic, category-wide study to examine the need for deeper patient education about the value of comprehensive consultations. The findings showed eight out of 10 patients move forward with aesthetic treatment after receiving a comprehensive assessment and aligning with their provider on a treatment plan incorporating two or more in-office products or procedures. 5   AA Signature: SKIN360 is tailored for patients who desire smoother, more hydrated skin. This assessment approach is designed to support HCPs as they explore different types of treatments to achieve patients' aesthetic goals with products in the Allergan Aesthetics portfolio. As part of the consultation process, aesthetic specialists may consider three products in an AA Signature: SKIN360 assessment † : SKINVIVE by JUVÉDERM ®  improves cheek skin smoothness, leading to increased hydration. 6 SkinMedica ®  HA 5®  Hydra Collagen Hydrator with Vegan Collagen supports immediate and long-lasting hydration, as well as visibly plump, dewy, healthier-looking skin. BOTOX ®  Cosmetic is an FDA-approved prescription medicine that works beneath the skin's surface to temporarily improve the appearance of moderate to severe platysma bands associated with platysma muscle activity, forehead lines, lateral canthal lines, and glabellar lines in adults. 7 "Since implementing the AA Signature: SKIN360 assessment in my practice, I've been able to take a more holistic approach to my patient consultations, extending them to assess concerns across the face, neck, and décolleté," said Emily Schultz, RN, CANS, board-certified aesthetic nurse specialist based in Ontario, Canada. "The program provides practical clinical tools that enhance consultation quality, support individualized treatment planning, and help patients better understand their aesthetic options." Subsequent aesthetic consultation protocols will debut through 2027 and will address key patient concerns, including lift, structure, skin firmness, and facial definition. Providers interested in additional resources and training materials may speak with their Allergan Aesthetics business development representative for more information. Patients interested in learning more about the Allergan Aesthetics portfolio are encouraged to book a consultation with a licensed aesthetic specialist. *According to a 2024 online survey of 155 patients. Includes filler patients who said they were "extremely, very, or somewhat interested." 2 † The safety and efficacy of these products for combined use have not been studied. — Company newsroom — sourced from AbbVie. Matter furnished by the company. Not a Notice Nearby paid placement. This page reprints matter furnished by the company from its official newsroom. Notice Nearby did not write this release. Read the original: https://news.abbvie.com/2026-09-22-Allergan-Aesthetics-Debuts-AA-Signature-TM-in-the-United-States-with-SKIN360,-Its-First-Multimodal-Consultation-Approach